Physician profile
Michael D Young
NPI 1023045838
$7,369.04
in general payments reported to CMS, 2019-2025
51 companies · $1,676 in 2025
The $1,676 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $638 · 2020: $1,031 · 2021: $45.36 · 2022: $546 · 2023: $1,729 · 2024: $1,703 · 2025: $1,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,108.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,314.79 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $990.50 | 2019-2025 | Vraylar, Linzess, Qulipta |
| Amgen INC. | $599.09 | 2019-2025 | Evenity, Prolia, Otezla |
| Lilly USA, LLC | $503.83 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Pfizer INC. | $407.06 | 2019-2025 | |
| Glaxosmithkline, LLC. | $367.51 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novartis Pharmaceuticals Corporation | $321.40 | 2019-2025 | |
| Exact Sciences Corporation | $217.57 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Corcept Therapeutics | $188.24 | 2020-2025 | Korlym |
| Xeris Pharmaceuticals, INC. | $183.60 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Astrazeneca Pharmaceuticals Lp | $172.82 | 2019-2025 | Farxiga, Bevespi Aerosphere |
| E.R. Squibb & Sons, L.L.C. | $166.56 | 2023 | Eliquis |
| Astellas Pharma US INC | $153.95 | 2019-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $152.35 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $116.26 | 2023-2025 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $110.06 | 2019-2025 | Trintellix |
| Abbott Laboratories | $95.01 | 2022-2025 | Freestyle Libre 3 |
| Tandem Diabetes Care, INC. | $92.26 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $83.83 | 2024-2025 | Rexulti |
| Sanofi-Aventis U.S. LLC | $83.00 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $63.87 | 2019-2023 | Belsomra |
| Averitas Pharma INC. | $62.00 | 2023-2025 | Qutenza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $61.02 | 2024-2025 | Caplyta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $60.16 | 2019-2023 | Xifaxan |
| Almatica Pharma LLC | $54.78 | 2023-2025 | Loreev Xr |
| Phathom Pharmaceuticals, INC. | $51.17 | 2024-2025 | Voquezna |
| Companion Medical, INC. | $48.49 | 2019 | |
| Mylan Specialty L.P. | $47.39 | 2019 | |
| Sumitomo Pharma America, INC. | $47.27 | 2024-2025 | Gemtesa |
| Biohaven Pharmaceutical Holding Company Ltd. | $47.08 | 2022 | |
| Medtronic, INC. | $45.63 | 2024 | Minimed 780g |
| Dexcom, INC. | $37.70 | 2023-2024 | Dexcom G6 Transmitter |
| Beta Bionics, INC. | $37.39 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Allergan, INC. | $35.13 | 2020-2021 | |
| Sanofi Pasteur INC. | $33.00 | 2020-2023 | |
| Idorsia Pharmaceuticals US INC | $30.91 | 2023-2024 | Quviviq |
| Kowa Pharmaceuticals America, INC. | $28.86 | 2025 | Zoryve |
| Daiichi Sankyo INC. | $26.96 | 2019-2020 | |
| Ultragenyx Pharmaceutical INC. | $26.80 | 2023 | |
| Antares Pharma, INC. | $26.51 | 2024 | Xyosted |
| Medtronic Minimed, INC. | $25.08 | 2020 | |
| Neurocrine Biosciences, INC. | $19.66 | 2025 | |
| Eisai INC. | $18.10 | 2020 | |
| Ibsa Pharma INC. | $17.65 | 2023 | Tirosint, Licart |
| Axsome Therapeutics, INC. | $16.62 | 2024 | Auvelity |
| Amarin Pharma, INC. | $15.45 | 2020 | |
| Jazz Pharmaceuticals INC. | $15.19 | 2019 | |
| Halozyme INC | $14.12 | 2023 | |
| Corium, LLC | $13.16 | 2023 | Azstarys |
| Teva Pharmaceuticals USA, INC. | $11.20 | 2020 | |
| Cequr Corporation | $11.00 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.